サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654676

血管造影装置の世界市場：2025年～2033年

Global Angiography Machine Market - 2025-2033

出版日
ページ情報
英文 149 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
血管造影装置の世界市場：2025年～2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 149 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血管造影装置の世界市場は、2024年に113億米ドルに達し、2033年までには190億米ドルに達すると予測され、予測期間中の2025年から2033年のCAGRは6.0%で成長すると予測されています。

血管造影装置は、体内の血管、動脈、静脈をリアルタイムで可視化するために使用される特殊な医療用画像システムです。X線、CT、MRI技術を利用し、造影剤と組み合わせて、閉塞、動脈瘤、血管奇形などの異常を検出することが多いです。この血管造影装置は、現代医療における重要な診断・介入ツールであり、血管をリアルタイムで可視化することで、様々な心血管・神経疾患の診断・治療を可能にします。その進化には、AIベースのイメージング、ハイブリッドシステム、モバイルユニットが含まれ、医療診断におけるアクセシビリティと精度を向上させています。

血管造影装置の需要は、心血管疾患の有病率の上昇、技術の進歩、低侵襲処置の採用の増加など、いくつかの重要な要因によって急成長しています。例えば、疾病管理予防センターによると、33秒に1人が心血管疾患で死亡しています。2022年には70万2,880人が心臓病で死亡します。これは死亡者の5人に1人に相当します。心血管疾患の増加に伴い、冠動脈疾患、末梢動脈疾患、その他の血管の問題を診断するための血管造影装置の需要が急増しています。

市場力学：

促進要因と抑制要因

技術進歩の高まり

技術進歩の高まりが血管造影装置市場の成長を大きく後押ししており、予測期間中も市場を牽引していくと予想されます。これらの技術革新は、診断精度の向上、患者リスクの最小化、効率の向上をもたらし、血管造影装置をより身近で望ましいものにしています。3D血管造影は血管の可視化方法に革命をもたらしました。これらの技術は、複雑な血管構造をよりよく可視化することを可能にし、これは血管手術やステント留置において特に重要です。

例えば、2022年9月、Siemens Healthineersはインドで血管造影システムARTIS iconoを発売しました。この血管撮影システムは、2Dおよび3D画像処理機能が大幅に改善されており、画質の向上と必要な放射線の低減を実現しています。頭蓋底と頭蓋は、Sine SpinによりCアームの動きが改善され、アーチファクトがほとんどなく、3Dで描写されます。ARTIS icono Biplaneは、脳卒中センターがより多くの患者を、より早く、より正確に治療するという複合的な課題に対応できるよう支援します。

人工知能（AI）アルゴリズムは現在、血管造影システムに統合され、放射線技師が血管の閉塞、動脈瘤、狭窄などの異常を自動的に検出するのを支援しています。例えば、AI技術はフラットパネル検出器（FPD）血管撮影システムに組み込まれ、画像の鮮明さと血管異常の自動検出を強化し、人為的ミスを減らして診断精度を向上させています。

放射線被曝の懸念

血管造影は血管疾患に対する最も効果的な診断・介入手段の一つですが、放射線被曝に対する懸念が血管造影の成長を制限する大きな要因となっています。このような懸念は患者とヘルスケア専門家の両方に影響し、血管造影装置の導入と利用に影響を及ぼしています。

血管造影装置による放射線被曝を長期間あるいは繰り返し受けると、放射線によるがんや皮膚障害、その他の長期的な健康問題のリスクが高まる可能性があります。このことは、冠動脈疾患（CAD）のような慢性疾患で頻繁に血管造影を必要とする患者にとって特に問題となります。

例えば、冠動脈造影を受ける患者は、長期にわたって高線量の放射線を蓄積する危険性があり、それががんのリスクにつながる可能性があります。JACC（Journal of the American College of Cardiology）に掲載された研究では、心臓血管造影を繰り返すことによる高累積放射線被曝は、典型的な患者の生涯発がんリスクを最大1.4％上昇させる可能性があることが明らかになりました。

放射線による健康リスクに対する認識が高まるにつれて、患者は血管造影検査を受けることをためらうようになり、特に繰り返し検査を受ける場合や、CT血管造影検査やMRI血管造影検査のような代替画像診断法が存在する場合には、そのような検査を受けることをためらう可能性があります。これにより、特定のヘルスケア環境における血管造影装置の需要が減少する可能性があります。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • スニペット：製品タイプ別
  • スニペット：技術別
  • スニペット：用途別
  • スニペット：エンドユーザー別
  • スニペット：地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 技術の進歩の高まり
    • 抑制要因
      • 放射線被曝の懸念
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名なプレーヤー
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 血管造影装置市場、製品タイプ別

  • X線血管造影装置
  • CT血管造影装置
  • 磁気共鳴血管造影装置
  • その他

第6章 血管造影装置市場、技術別

  • 2D血管造影
  • 3D血管造影
  • 回転血管造影検査
  • その他

第7章 血管造影装置市場、用途別

  • 冠動脈造影検査
  • 脳血管造影検査
  • 肺血管造影検査
  • 腎血管造影検査
  • 腹部血管造影検査
  • 四肢血管造影検査

第8章 血管造影装置市場、エンドユーザー別

  • 病院
  • 専門クリニック
  • 診断センター
  • 外科センター
  • その他

第9章 血管造影装置市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • Siemens Healthineers AG
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Canon Medical Systems ANZ Pty Limited.
  • GE HealthCare
  • Shimadzu Corporation
  • Koninklijke Philips N.V.
  • B. Braun SE

第12章 前提条件と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第13章 付録

目次
Product Code: MD9110

The global angiography machine market reached US$ 11.3 billion in 2024 and is expected to reach US$ 19.0 billion by 2033, growing at a CAGR of 6.0% during the forecast period 2025-2033.

An angiography machine is a specialized medical imaging system used to visualize the blood vessels, arteries, and veins of the body in real time. It utilizes X-ray, CT, or MRI technology, often combined with a contrast agent, to detect abnormalities such as blockages, aneurysms and vascular malformations. This angiography machine is a critical diagnostic and interventional tool in modern medicine, enabling real-time visualization of blood vessels to diagnose and treat various cardiovascular and neurological conditions. Its evolution includes AI-based imaging, hybrid systems, and mobile units, improving accessibility and accuracy in medical diagnostics.

The demand for angiography machines is growing rapidly due to several key factors, including the rising prevalence of cardiovascular diseases, advancements in technology, and the increasing adoption of minimally invasive procedures. For instance, acording to the Centers for Disease Control and Prevention, one person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That's the equivalent of 1 in every 5 deaths. As the cardiovascular diseases increase, demand for angiography machines has surged to diagnose coronary artery disease, peripheral artery disease and other vascular issues.

Market Dynamics: Drivers & Restraints

Rising technological advancements

The rising technological advancements is significantly driving the growth of the angiography machine market and is expected to drive the market over the forecast period. These innovations are improving diagnostic accuracy, minimizing patient risk and enhancing efficiency, making angiography machines more accessible and desirable. 3D angiography have revolutionized the way blood vessels are visualized. These technologies allow for better visualization of complex vascular structures, which is especially important for vascular surgeries and stent placements.

For instance, in September 2022, Siemens Healthineers launched ARTIS icono, an angiography system, in India. The angiography system has much improved 2D and 3D imaging capabilities, which improve picture quality and reduce radiation requirements. The cranial base and skull cap may be portrayed in 3D with virtually no artifacts to improved C-arm movement with Sine Spin. ARTIS icono Biplane will assist stroke centers in meeting the combined challenge of treating more patients, faster, and with more precision.

Artificial Intelligence (AI) algorithms are now being integrated into angiography systems to assist radiologists in automatically detecting abnormalities such as blockages, aneurysms, or stenosis in blood vessels. For instance, AI technologies are being incorporated into flat-panel detector (FPD) angiography systems to enhance image clarity and automatic detection of vascular anomalies, reducing human error and improving diagnostic accuracy.

Radiation exposure concerns

While angiography remains one of the most effective diagnostic and interventional tools for vascular diseases, concerns over radiation exposure are a significant factor limiting its growth. These concerns affect both patients and healthcare professionals, influencing the adoption and utilization of angiography machines.

Prolonged or repeated exposure to radiation from angiography machines can increase the risk of radiation-induced cancers, skin damage and other long-term health issues. This is particularly concerning for patients who require frequent angiography procedures for chronic conditions like coronary artery disease (CAD).

For instance, patients undergoing coronary angiography are at risk of accumulating high doses of radiation over time, which can lead to cancer risks. A study published in JACC (Journal of the American College of Cardiology) found that high cumulative radiation exposure from repeated cardiac angiography could raise the lifetime risk of cancer by up to 1.4% for a typical patient.

As awareness about radiation-induced health risks grows, patients may become hesitant to undergo angiography procedures, especially in the case of repeated scans or when alternative imaging methods like CT angiography or MRI angiography exist. This can reduce the demand for angiography machines in certain healthcare settings.

Segment Analysis

The global angiography machine market is segmented based on product type, technology, application, end-user and region.

Application:

The coronary angiography segment is expected to dominate the angiography machine market share

Cardiovascular diseases are the leading cause of death worldwide, with coronary artery disease (CAD) being one of the most common types of heart disease. As the global population ages and lifestyle-related risk factors such as obesity, diabetes, and smoking increase, there is a corresponding rise in the demand for coronary angiography to detect and treat these conditions.

For instance, the World Health Organization (WHO) reports that cardiovascular diseases account for 32% of global deaths, with coronary artery disease (CAD) being a major contributor. This has led to a high demand for coronary angiography as the gold standard for diagnosing blockages and narrowing of coronary arteries.

Coronary angiography is considered the gold standard for diagnosing coronary artery disease (CAD), providing a clear view of the coronary arteries, allowing cardiologists to evaluate blockages, stenosis, and the need for interventional procedures. For instance, in North America and Europe, coronary angiography is widely used in cardiac catheterization labs (Cath Labs) for diagnosis and treatment planning of patients with chest pain, shortness of breath, or risk factors for CAD, making it the dominant use case for angiography systems in these regions.

Geographical Analysis

North America is expected to hold a significant position in the angiography machine market share

North America particularly the United States is a hub for innovation in medical imaging technologies, and this extends to the angiography market. Continuous advancements in 3D imaging, digital subtraction angiography, real-time image guidance and AI integration have positioned North America at the forefront of adopting next-generation angiography systems.

For instance, Philips Healthcare and GE Healthcare, two major players in the angiography market, have developed cutting-edge systems such as the Philips Azurion and GE Innova platforms, which offer superior imaging clarity and reduced radiation exposure. These advanced systems are widely used across North America in cardiology, vascular surgery, and interventional radiology.

North America leads the adoption of hybrid angiography systems that combine traditional angiography with CT, MRI, or 3D imaging to provide a more comprehensive diagnostic approach. These systems offer real-time imaging and guidance, making them particularly useful for minimally invasive procedures like angioplasty, stent placement, and neurovascular interventions.

For instance, the growing trend of hybrid operating rooms, particularly in U.S. hospitals, is a key factor driving the demand for advanced angiography machines. Hybrid ORs integrate angiography systems with CT/MRI imaging, providing the flexibility to perform complex procedures like cardiac bypass surgeries and endovascular aneurysm repairs in a single setting.

Asia-Pacific is growing at the fastest pace in the angiography machine market

Cardiovascular diseases are on the rise in Asia-Pacific due to aging populations, urbanization, and the growing prevalence of risk factors such as smoking, poor diet, and lack of physical activity. As a result, there is an increasing demand for angiography as a diagnostic tool to detect and treat conditions like coronary artery disease (CAD), stroke, and peripheral artery disease (PAD).

For instance, in China, heart disease is the leading cause of death, with a significant rise in coronary artery disease cases, prompting the need for advanced diagnostic tools like angiography. According to the World Health Organization (WHO), more than 4 million deaths in China are attributed to CVDs, leading to growing demand for angiography procedures.

Medical tourism in APAC is also contributing to the growth of the angiography machine market, as countries like India, Thailand, and Singapore attract patients from developed countries seeking affordable, high-quality medical care. Many international patients travel to APAC for heart surgeries, angioplasties, and angiography due to the region's cost-effectiveness and high-quality healthcare services.

For instance, India is a major medical tourism destination, especially for cardiac procedures. Hospitals in cities like New Delhi, Chennai, and Bangalore are equipped with state-of-the-art angiography systems to cater to both local and international patients.

Competitive Landscape

The major global players in the angiography machine market include Siemens Healthineers AG, Canon Medical Systems ANZ Pty Limited., GE HealthCare, Shimadzu Corporation, Koninklijke Philips N.V., B. Braun SE and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global angiography machine market report delivers a detailed analysis with 58 key tables, more than 65 visually impactful figures, and 149 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Radiation Exposure Concerns
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Angiography Machine Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. X-ray Angiography Machines*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. CT Angiography Machines
  • 5.4. Magnetic Resonance Angiography Machines
  • 5.5. Others

6. Angiography Machine Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. 2D Angiography*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. 3D Angiography
  • 6.4. Rotational Angiography
  • 6.5. Others

7. Angiography Machine Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Coronary Angiography*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cerebral Angiography
  • 7.4. Pulmonary Angiography
  • 7.5. Renal Angiography
  • 7.6. Abdominal Angiography
  • 7.7. Extremity Angiography

8. Angiography Machine Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Surgical Centers
  • 8.6. Others

9. Angiography Machine Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Siemens Healthineers AG*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Canon Medical Systems ANZ Pty Limited.
  • 11.3. GE HealthCare
  • 11.4. Shimadzu Corporation
  • 11.5. Koninklijke Philips N.V.
  • 11.6. B. Braun SE

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us